SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Sick Visit — Ada Lovelace — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientAda Lovelace
Date of birth1815-12-10
IdentifiersMRN HR-NI031-SYN-TD; SSN (made up) 000-31-6729
Document date1851-07-07
AuthorConstance Whitley-Adeyemi, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

No bowel movement for five days, with bloating and cramps. [S]

History of Present Illness

Mrs. Lovelace asked for a same-day visit. She had her first cycle of carboplatin, paclitaxel and pembrolizumab a week ago and took ondansetron twice a day for three days after it. She takes long-acting morphine 15 mg twice a day, with one or two 5 mg doses of the oral solution on some days, senna two tablets at night and polyethylene glycol once a day, though she missed some doses of the laxatives while she felt sick. She has not opened her bowels for five days. She feels bloated with cramping in the lower abdomen, but she is passing wind, has not vomited, and is eating a little. She has no fever. The vaginal bleeding has stopped since the radiation. Her pelvic pain is no worse. [S]

ElementDetail
OnsetNo bowel movement since five days ago
LocationLower abdomen
DurationFive days
CharacterBloating and cramping
SeverityCramps 4 of 10
TimingConstant bloating; intermittent cramps
ContextFirst chemotherapy cycle a week ago; ondansetron for three days; long-acting morphine; missed laxative doses
Modifying factorsPassing wind eases the cramps
Associated signs and symptomsMild nausea; no vomiting, fever, or bleeding

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or chills
GastrointestinalPositiveNo stool for five days, bloating, cramps, mild nausea; passing wind; no vomiting or blood
GenitourinaryNegativeNo vaginal bleeding; passing urine normally
NeurologicalNegativeNo confusion or drowsiness

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Opium tincture (100 mg/mL opium, equivalent to 10 mg/mL morphine), 0.5 mL by mouth four to six times a day as needed for pain0.5 mL four to six times a day as neededOral route1849-06-03 to 1851-06-02completedS
Morphine sulfate oral solution 2 mg/mL, 5 mg (2.5 mL by oral syringe) every 4 hours as needed for pain5 mg every 4 hours as neededOral route1851-06-02activeS
Morphine sulfate extended-release 15 mg tablet, one tablet by mouth every 12 hours; swallow wholeevery 12 hoursOral route1851-06-16 to 1851-10-20completedS
Naloxone 4 mg nasal spray, one spray in a nostril for suspected opioid overdose; call 911one spray as needed for suspected overdose; repeat after 2 to 3 minutes if neededNasal route1851-06-02activeS
Senna 8.6 mg tablet, two tablets by mouth at nighttwo tablets at nightOral route1851-06-02activeS
Polyethylene glycol 3350, 17 g in water by mouth once or twice a dayonce daily, up to twice dailyOral route1851-06-02activeS
Acetaminophen 500 mg tablet, two tablets by mouth three times a day1 g three times a dayOral route1851-06-02activeS
Ferric carboxymaltose 750 mg intravenous infusion, two doses at the first two visits750 mg on two occasions two weeks apartIntravenous route1851-06-02 to 1851-06-17completedS
Pembrolizumab 200 mg intravenously every 3 weeksevery 3 weeksIntravenous route1851-06-30activeS
Carboplatin, dose to an AUC of 5 (650 mg), intravenously every 3 weeks for six cyclesevery 3 weeks for six cyclesIntravenous route1851-06-30 to 1851-10-13completedS
Paclitaxel 175 mg/m2 (275 mg) intravenously every 3 weeks for six cycles, with premedicationevery 3 weeks for six cyclesIntravenous route1851-06-30 to 1851-10-13completedS
Ondansetron 8 mg tablet, one tablet by mouth twice a day for three days after each chemotherapy cycle, then as neededtwice a day for three days after each cycle, then as neededOral route1851-06-30activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1851-07-07Body height165cmS
1851-07-07Body weight53.8kgS
1851-07-07Body mass index (BMI) [Ratio]19.8kg/m2S
1851-07-07Systolic blood pressure110mm[Hg]S
1851-07-07Diastolic blood pressure70mm[Hg]S
1851-07-07Heart rate88/minS
1851-07-07Respiratory rate16/minS
1851-07-07Body temperature36.7CelS
1851-07-07Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1851-07-07Potassium [Moles/volume] in Serum or Plasma3.8mmol/L3.5-5.1 mmol/LNormalS
1851-07-07Calcium [Mass/volume] in Serum or Plasma9.3mg/dL8.6-10.3 mg/dLNormalS

Physical Exam

Vital signs recorded on 1851-07-07; see the Vital Signs section. [S]

SystemFinding
GeneralComfortable at rest; temperature 36.7 C, blood pressure 110/70, pulse 88
AbdomenMildly distended and soft, with active bowel sounds; mild tenderness in the left lower quadrant over palpable stool; no guarding, rebound, or tympanic distension
Mental statusAlert and clear; pupils normal size; not sedated

Problems

ProblemClinical statusVerificationCodeProvenance
Bleeding between periods and after intercourse, with heavier periods, a watery blood-stained discharge and a constant pelvic ache, for about five months; average pain 7 of 10 despite her opium tincture; a friable cervical mass found on examination and biopsied; cause not yet established at intakeresolvedconfirmed N93.8S — Synthetic presenting problem anchored to her documented final illness; superseded by the diagnosis at the second visit.
Iron deficiency anemia from chronic blood loss: hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, with tiredness and breathlessness on stairsactiveconfirmed D50.0S — Synthetic modern finding anchored to her documented final illness.
Adenocarcinoma of the endocervix, usual (HPV-associated) type, HPV 18 positive, FIGO 1843 stage IVB: a 5.2 cm tumor with left parametrial invasion, metastases to left pelvic and para-aortic lymph nodes, and bilateral lung metastases on MRI and PET-CT; PD-L1 combined positive score 5, mismatch repair proficient, HER2 1+; treated with palliative pelvic radiation for bleeding and carboplatin, paclitaxel and pembrolizumab, with specialist palliative care from diagnosisactiveconfirmed C53.0S — Synthetic modern diagnosis made at the second visit, anchored to her documented uterine cancer; the cervical site is a synthetic choice.
Cancer-related pelvic pain, nociceptive and visceral, from the cervical tumor and its left parametrial extensionactiveconfirmed G89.3S — Synthetic modern diagnosis made at the second visit.
Long-term prescribed opioid therapy: opium tincture for recurrent pelvic and abdominal pain for about two years, measured at times with a household spoon, converted at intake to measured oral morphine; no opioid use disorder on a DSM-5 assessment; naloxone suppliedactiveconfirmed Z79.891S — Synthetic modern history anchored to her documented laudanum and opium; not a claim about her real dosing.
Drug-induced constipation from long-acting morphine and ondansetron, a week after the first chemotherapy cycle: no bowel movement for five days, with bloating and cramping but passing wind, without vomiting; no bowel obstruction on examination; potassium and calcium normal; resolved with laxativesresolvedconfirmed K59.03S — Synthetic adverse drug effect; not a historical claim.

Assessment and Plan

Guideline basis: Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline (Paice JA, et al. J Clin Oncol 2023;41:914-930) (2023)

Follow-up: Telephone check in two days. Six-week review next week. Next scheduled visit 1851-07-14: six-week review: bleeding and pain after palliative pelvic radiation, the first cycle of chemotherapy with pembrolizumab, blood counts, mood and opioid safety. [S]